Fact-check: Vitamin C and kidney stones

Vitamin C is one of the best-studied micronutrients, credited with protecting cells from oxidative stress, improving absorption of plant-based iron, and enabling collagen synthesis for skin, blood vessels, and connective tissue. Its immune support makes supplementation popular in autumn as colds rise. Yet periodic warnings claim that “high” vitamin C intakes promote kidney stones. The concern stems from the fact that some vitamin C is metabolized into oxalate, a component of many stones. However, stone formation is multifactorial—shaped by diet, hydration, genetics, infections, and comorbidities—and newer analyses even hint that moderate dietary vitamin C may relate to lower risk. Despite this, outdated teaching persists and leads some clinicians to discourage supplementation without solid evidence that doing so prevents stones or outweighs vitamin C’s benefits.

Historically, the charge against vitamin C rests on shaky ground. In 1998, Goodwin and Tangum traced the references behind a widely cited 1984 review ominously titled “The Toxic Effects of Water-Soluble Vitamins.” Of seven citations used to implicate vitamin C in stone formation, one proved to be a 1973 Lancet letter reporting anecdotal cases; one was off-topic; and five were books rather than experimental studies. Only two of those books even attempted sourcing, ultimately circularly referencing the same letter or internal chapters. This slender foundation nonetheless spread through medical literature and public media, planting a durable myth.

Types of kidney stones: Understanding stone subtypes clarifies where vitamin C could plausibly help or harm. Calcium oxalate stones are most common (roughly 60–70%). Because oxalate appears in foods like spinach and rhubarb, and its solubility depends on urine chemistry, it dominates the conversation. Uric acid stones are the second most prevalent (about 9–17% in adults), typically tied to purine metabolism (e.g., gout). Calcium phosphate stones form in alkaline urine and dissolve more readily in acidic urine; vitamin C mildly acidifies urine and therefore may help prevent their formation or aid dissolution. Struvite stones (magnesium–ammonium–phosphate) arise with certain urinary tract infections, can grow large, and are responsive to urine acidification; by lowering infection risk, higher vitamin C intakes may indirectly reduce struvite risk. Cystine stones, caused by an inherited transport defect, are rare (about 1%).

Frequency of kidney stones: Kidney stones are common: 5–10% of people will develop them over a lifetime, with men affected more than women. Men’s risk tends to rise after age 40, whereas women’s risk often increases around menopause. First-time stones are appearing earlier than in past decades: today, about 13% of affected men and nearly 20% of affected women report their first stone before age 20, compared with roughly 5% and 4% in 1975. Pregnancy can elevate risk, and recurrence is frequent.

Sources of oxalate: Because calcium oxalate stones predominate, oxalate intake and handling deserve attention. Most urinary oxalate originates from diet and endogenous metabolism; only a small fraction comes from vitamin C degradation. Oxalate content varies dramatically across foods: spinach and rhubarb are high; almonds, beetroot, wheat bran, tea, and coffee contribute meaningful loads in everyday diets. Average adult intake often ranges from 80 to 150 mg/day but can span 44 to 1000 mg/day. By comparison, 1000 mg/day of supplemental vitamin C is estimated to add only about 20–30 mg of oxalate. Intestinal absorption of dietary oxalate typically ranges from ~2–15%, depending on the food matrix.

Managing oxalate formation: Simple tactics can reduce oxalate absorption. Co-ingesting calcium—especially calcium citrate—binds oxalate in the gut to form insoluble complexes that exit in stool; citrate may independently inhibit oxalate uptake. The gut microbiome also matters: strains such as Oxalobacter, Bifidobacterium lactis, and Lactobacillus acidophilus degrade oxalate. Individuals with low levels of these bacteria often show higher stone susceptibility.

Endogenously, the liver produces oxalate from the breakdown of certain amino acids (e.g., glycine, hydroxyproline, tryptophan), sugars (e.g., glucose, fructose), and intermediates like glyoxal/glyoxylate. Only about 1–1.5% of intracellular vitamin C is converted to oxalate. Several mechanisms make vitamin C an unlikely driver of calcium oxalate stones: it can bind calcium in urine (reducing free calcium available to pair with oxalate), it acidifies urine (disfavoring crystal formation), and it has a mild diuretic effect that increases urine flow and reduces stasis. Certain infections, including some fungal infections (Aspergillus), may also increase oxalate production independently of vitamin C.

Studies disproving vitamin C intake – kidney stones connection: What does the evidence say? Robust randomized, long-term trials directly linking vitamin C supplementation to stone events are lacking. Most data come from observational cohorts and short metabolic studies. Several large analyses do not support a causal link. In a Harvard cohort of more than 45,000 men, those consuming over 1500 mg/day of vitamin C had a lower stone risk than men with lower intakes. Pooled analyses of two large cohorts indicated that up to 1 g/day had no effect on risk in women; a reported 19% higher risk in men was statistically borderline and lacked stone-type information. A 14-year study of more than 85,000 women found no increased risk even at ≥1.5 g/day, concluding there is no reason to restrict higher vitamin C intakes in women. An uncontrolled intervention providing 10 g/day for two years to healthy adults found no clinically meaningful rise in urinary oxalate in five of six participants and only a modest, within-normal-range increase in one. A narrative review reached a similar conclusion: no demonstrable effect of vitamin C on calcium oxalate stone formation.

Weakness in the evidence linking vitamin C to kidney stones: Studies hinting at risk carry notable limitations. A 2013 analysis speculated elevated risk among supplement users but it neither examined stones to confirm oxalate composition nor accurately quantified vitamin C doses. A Swedish observational study of more than 23,000 individuals reported a small absolute risk difference—about 1–2 additional cases per 1000 supplement users—yet lacked dietary detail and stone analyses. A short metabolic study administering 2 g/day raised urinary oxalate in some participants after a low-oxalate run-in, but no stones occurred; the result mainly reflects increased oxalate handling, not clinical events.

Prevention of kidney stones: Prevention is multifaceted and more impactful than avoiding vitamin C intake. These include: maintain high fluid intake to dilute urinary solutes; choose beverages wisely (coffee and tea associate with lower risk, whereas apple and grapefruit juices associate with higher risk); ensure adequate minerals—potassium (boosts urinary citrate, an inhibitor of crystallization), magnesium (may reduce stone formation), and calcium (binds oxalate in the gut), with citrate salts preferred for bioavailability and added citrate benefits; support vitamin B status—especially B6—to limit endogenous oxalate formation; and consider targeted probiotics (e.g., Oxalobacter) that can lower urinary oxalate. Limiting excessive animal protein and high fructose intake and correcting chronically low hydration are also important levers.

Bottom line: The longstanding claim that vitamin C meaningfully increases kidney-stone risk is not supported by strong, consistent evidence and originated from weak citations. While individual variation exists and medical advice should be personalized for those with specific metabolic disorders, there is no clear reason to avoid vitamin C—even at relatively high intakes—when the goal is to prevent stones. Focus on hydration, smart beverage choices, adequate citrate-rich minerals, B-vitamins, and microbiome support for practical risk reduction.

Link to the original article with references.